Linna

Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical

Tuesday, February 23, 2021 - 1:00pm

Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc.(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)(the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linna Olofsson as an advisor and consultant for the Company.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc.(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)(the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linna Olofsson as an advisor and consultant for the Company.
  • Her contribution to execute strategic marketing plans increased U.S. sales from $3.2 million in 2018 to $6.7 million in 2019.
  • Dr. Linna Olofsson commented, "I'm beyond thrilled and honoured for this opportunity to join PreveCeutical as an advisor.
  • PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.